Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD Support
NCT07445932
Advanced Heart Failure, Left Ventricular Assist Device
Washington D.C., District of Columbia, United States
View Trial DetailsNCT Number: NCT07526181
for patients connected to VA ECMO due to cardiogenic shock, monitoring:
1. Cerebral Oximetry 2. ECMO Parameters ECMO blood flow (L/min) every 12 hours. Sweep gas flow Cannulation configuration 3. Pulmonary Artery Catheter Data and hemodynamics:
Cardiac output / cardiac index, SvO₂, Central venous pressure (CVP). 4. other variables: P/F ratio, MAP, Heart rate, Arterial blood gases, hemoglobin, Lactate, Vasopressor / inotrope doses and Sedation score (RASS). 5. Echocardiography parameters: recorded every 12 hours. LV ejection fraction. LVOT VTi. LVED dimension. Aortic valve opening. 6. Follow-up data:
* ECMO duration. * Need for oxygen therapy/mechanical ventilation. * ICU survival.
Trial opening soon.
Get Notified18 year–80 year
All sexes
Observational
for patients connected to VA ECMO due to cardiogenic shock, monitoring:
Bilateral frontal sensors, rScO₂ recorded:
at baseline (within 1 hour of ECMO initiation) then every 12 hours.
Cardiac output / cardiac index every 12 hours. SvO₂. Central venous pressure (CVP) Mean pulmonary artery pressure. Pulmonary capillary wedge pressure. Systemic vascular resistance.
P/F ratio. MAP. Heart rate. Arterial blood gases. Lactate. Hemoglobin. Vasopressor / inotrope doses. Sedation score (RASS).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from date of randomization until the date of ending the ECMO support (assessed up to 100 weeks)
Contact information is provided by the study sponsor or research team.
Assiut University
Other
Cerebral Oximetry in Relation to Pulmonary Artery Catheter Parameters and Extracorporeal Membrane Oxygenation Flow in Patients Supported With Veno-arterial ECMO
Acronym: ECMO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07445932
Advanced Heart Failure, Left Ventricular Assist Device
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07323238
Cardiogenic Shock, Cardiogenic Shock Acute
Hong Kong, Shatin
View Trial DetailsNCT07296744
Arterial Occlusive Diseases, Arteriosclerosis
Loma Linda, California, United States
View Trial DetailsNCT07633535
End-stage Heart Failure, Left Ventricular Assist Device
Antalya, Turkey (Türkiye)
View Trial Details